Our Vision

Imagine life without brain disease.


We bring researchers and donors together to cure brain diseases and disorders.

Celebrating Brain Disease Research

Join Us for Commitment to Cures 2021

Join us for an inspiring night honoring just how far we’ve come in the fight against brain disease. The event will include celebrity appearances, a live musical performance and craft cocktail demo, inspiring stories from those impacted by brain disease, a live fund-a-need and more!

Don’t miss your chance to help us recognize research breakthroughs and raise funds to continue this critical work.

Our Statement on Injustice, Inequality and Racism

We join our fellow Americans in expressing our sadness and revulsion at the killing of George Floyd. This horrific event reminds us how racism permeates healthcare, social and economic systems, obstructing access for people of color. Life without brain disease means life without brain disease for everyone. We are determined to do better.

COVID-19 Information

Updates from Our Research Partner on Coronavirus

We know how deeply the medical and patient communities are affected by the COVID-19 health care crisis. Our research partner, the American Academy of Neurology is providing updated information on the novel coronavirus pandemic.

Meet Ken Keene Jr.

Before frontotemporal lobe dementia, sometimes called Pick’s disease, Ken Keene Sr. was a respected community member and a handy man who could fix anything. For his oldest son and namesake Ken Keene Jr., there was nothing his father couldn’t do: “To my family, he was just that super dad. Then all of a sudden he’s reaching out for help.”

Ken Keene Jr. and Ken Keene Sr. working together to fight dementia
Inspired To Find A Cure

Meet Suma Babu, MBBS, MPH

Dr. Babu’s goal is to understand the inflammatory and neurodegenerative changes in the spinal cords of people living with ALS. Her team’s study addresses important, under-studied, disease mechanism-related research questions with potential implications for improving clinical trial designs in ALS.